Nan Fung Group Holdings LTD Kura Oncology, Inc. Transaction History
Nan Fung Group Holdings LTD
- $103 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding KURA
# of Institutions
197Shares Held
82.7MCall Options Held
42.1KPut Options Held
34K-
Suvretta Capital Management, LLC New York, NY7.65MShares$63.8 Million5.88% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$58.1 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$48.4 Million4.92% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$45.1 Million1.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$40.2 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $558M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...